(Q40356020)

19 September 2017

title

GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing (English)

1 reference

19 September 2017

1 reference

Djafarzadeh R

1

1 reference

19 September 2017

Noessner E

2

1 reference

19 September 2017

Engelmann H

3

1 reference

19 September 2017

Schendel DJ

4

1 reference

19 September 2017

Notohamiprodjo M

5

1 reference

19 September 2017

von Luettichau I

6

1 reference

19 September 2017

Nelson PJ

7

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

25

1 reference

19 September 2017

issue

10

1 reference

19 September 2017

page(s)

1496-1508

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209188

19 September 2017

exact match

0 references

cites work

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Isolation, structure and genetics of HLA-A, -B, -C and -DRw (Ia) antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidylinositol (GPI) membrane anchor in neurons and polarised epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

The three Es of cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Death and anti-death: tumour resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Matrix metalloproteinases in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

The melanoma progression-associated antigen P3.58 is identical to the intercellular adhesion molecule, ICAM-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

LFA-3 delta D2: a novel in vivo isoform of lymphocyte function-associated antigen 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Chemokine-Induced secretion of gelatinase B in primary human monocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Cell-surface engineering with GPI-anchored proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Fas ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

1 reference

7 January 2021

AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209188

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209188

1 reference

Dimensions Publication ID

19 September 2017

1048888629

0 references

1 reference